Status:
ACTIVE_NOT_RECRUITING
Evaluation of the Uterine Cavity in Perimenopausal Women.
Lead Sponsor:
Suez University
Conditions:
Abnormal Uterine Bleeding, Unspecified
Eligibility:
FEMALE
40-55 years
Brief Summary
Abnormal uterine bleeding (AUB) in perimenopausal women is a common yet poorly defined condition requiring accurate diagnosis. Hysteroscopy is the gold standard for evaluating intrauterine abnormaliti...
Detailed Description
Change in menstrual blood volume is a common manifestation of perimenopause, often indicative of underlying gynecological conditions. The etiology of perimenopausal bleeding is multifactorial and may ...
Eligibility Criteria
Inclusion
- Age: 40 -55 years.
- Patients complaining of abnormal uterine bleeding not receiving hormonal treatment for the last three months or intrauterine device as it affects the endometrial thickness by ultrasound and the accuracy of the pathology.
- Free from chronic medical diseases: renal, liver, chest and heart diseases.
Exclusion
- Age less than 40 and more than 55 years.
- Patients received hormonal treatment.
- Patients with chronic diseases or have coagulopathy.
Key Trial Info
Start Date :
February 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06888414
Start Date
February 1 2025
End Date
May 31 2025
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of medicine, Suez university
Suez, Egypt, 43221